The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KEYNOTE-667: Phase 2, open-label study of pembrolizumab in children and young adults with newly diagnosed classical Hodgkin lymphoma (cHL) with slow early response (SER) to frontline chemotherapy.
 
Christine Mauz-Korholz
No Relationships to Disclose
 
Kara M. Kelly
No Relationships to Disclose
 
Frank G. Keller
No Relationships to Disclose
 
Lisa Giulino-Roth
No Relationships to Disclose
 
Akash Nahar
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Arun Balakumaran
Employment - Merck
Stock and Other Ownership Interests - Merck